Z. Peter Wang
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Circular RNAs in diseases
- Histone Deacetylase Inhibitors Research
Papers in
-
- Renal and related cancers 2
- Extracellular vesicles in disease 2
- Epigenetics and DNA Methylation 2
- Connective Tissue Growth Factor Research 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- MicroRNA in disease regulation 3
- Co-authors
- Jia Ma (9 shared papers)Jun Xia (5 shared papers)Yuyun Li (3 shared papers)Jing Liu (1 shared paper)Yi Liu (1 shared paper)Wenyi Wei (1 shared paper)Tong Cao (5 shared papers)Yisheng Tao (7 shared papers)
- Journals
- Molecular Therapy — Nucleic Acids (2 papers)Molecular Therapy — Oncolytics (2 papers)Cancer Letters (1 paper)Journal of Translational Medicine (1 paper)Seminars in Cancer Biology (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Z. Peter Wang
18 papers receiving 536 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 107
- Molecular Biology 371
- Oncology 103
- Sensory Systems 18
- Hematology 38
Countries citing papers authored by Z. Peter Wang
This map shows the geographic impact of Z. Peter Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. Peter Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. Peter Wang more than expected).
Fields of papers citing papers by Z. Peter Wang
This network shows the impact of papers produced by Z. Peter Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. Peter Wang. The network helps show where Z. Peter Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Z. Peter Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 154 | |
| 2 | 2019 | 50 | |
| 3 | 2018 | 46 | |
| 4 | 2019 | 41 | |
| 5 | 2019 | 34 | |
| 6 | 2019 | 31 | |
| 7 | 2019 | 26 | |
| 8 | 2019 | 22 | |
| 9 | 2020 | 21 | |
| 10 | Nitidine Chloride inhibits cell proliferation and invasion via downregulation of YAP expression in prostate cancer cells. | 2019 | 21 |
| 11 | 2019 | 19 | |
| 12 | 2019 | 18 | |
| 13 | 2019 | 15 | |
| 14 | Tumor suppressive role of rottlerin in cancer therapy. | 2018 | 15 |
| 15 | Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma with a micropapillary pattern: cases report and literature review. | 2019 | 8 |
| 16 | Lymphoma of the female genital tract: a clinicopatholngical analysis of 25 cases. | 2019 | 8 |
| 17 | Ollier disease: two case reports and a review of the literature. | 2018 | 6 |
| 18 | 2024 | 5 | |
| 19 | 2026 | 0 | |
| 20 | 2026 | 0 |
About Z. Peter Wang
Z. Peter Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Cell Biology, having authored 20 papers that have together received 540 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Renal and related cancers (2 papers), Extracellular vesicles in disease (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Epigenetics and DNA Methylation (2 papers), Connective Tissue Growth Factor Research (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Cancer Research (107 citations), Molecular Biology (371 citations), Oncology (103 citations), Sensory Systems (18 citations) and Hematology (38 citations). Z. Peter Wang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jia Ma, Jun Xia, Yuyun Li, Jing Liu, Yi Liu, Wenyi Wei, Tong Cao, Yisheng Tao, Miaomiao Ye and Xueqiong Zhu. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Molecular Therapy — Oncolytics, Cancer Letters, Journal of Translational Medicine and Seminars in Cancer Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.